Purpose
This page provides information about independent peer review of documents defined by DHP as influential in terms of their potential impact on public policy or the private sector. DHP makes this information available to demonstrate its efforts to use only the most transparent and independent peer review, appropriate research methods, and the highest level of data quality.
Scientific information quality
This information demonstrates compliance with the specific requirements of the Information Quality Act (2000), 44 U.S.C. §3516, and of peer review standards developed by the Office of Management and Budget (OMB), Department of Health and Human Services, and CDC. OMB requirements include making publicly available specific information on the peer review of influential documents disseminated by the federal government. OMB has defined two special categories of influential information, Influential Scientific Information and Highly Influential Scientific Assessments.
For issues related to the DHP Peer Review Agenda, please contact:
Information Quality Peer Review Staff Centers for Disease Control and Prevention Office of Extramural Research 1600 Clifton Road, NE MS D-72 Atlanta, GA 30333 peer.review@cdc.gov
Peer review agenda items
Updated recommendations for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV in the United States
- Peer review plan: Updated recommendations for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV in the United States (2016)
- Response to peer reviewer comments: Updated recommendations for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV in the United States
Updated recommendations for human immunodeficiency virus (HIV) screening of gay bisexual and other men who have sex with men (MSM) in clinical settings
- Peer review plan: Updated recommendations for human immunodeficiency virus (HIV) screening of gay bisexual and other men who have sex with men (MSM) in clinical settings
- Responses to peer review comments: Recommendations for HIV screening of gay, bisexual and other men who have sex with men (MSM) in clinical settings
Updated HIV preexposure prophylaxis (PrEP) clinical practice guideline and supplement
- Public comment webinar: Draft clinical practice PrEP guideline (2021)
- Public comment webinar transcript: PrEP guideline and providers supplement (May 24, 2021)
- Public comment webinar transcript: PrEP guideline and providers supplement (May 25, 2021)
- Public comments and CDC responses: Draft clinical practice guideline and providers supplement (2021)
Information for providers to share with male patients and parents regarding male circumcision and the prevention of HIV infection, sexually transmitted infections, and other health outcomes*
- Background, methods, and synthesis of scientific information: Information for providers to share with male patients and parents regarding male circumcision and the prevention of HIV infection, sexually transmitted infections, and other health outcomes**
- Peer review comments and CDC responses: Information for providers to share with male patients and parents regarding male circumcision and the prevention of HIV infection, sexually transmitted infections, and other health outcomes and background, methods, and synthesis of scientific information: Information for providers to share with male patients and parents regarding male circumcision and the prevention of HIV infection, sexually transmitted infections, and other health outcomes
- Public comments and CDC responses: Information for providers to share with male patients and parents regarding male circumcision and the prevention of HIV infection, sexually transmitted infections, and other health outcomes
- Peer review comments and CDC responses (second round): Information for providers to share with male patients and parents regarding male circumcision and the prevention of HIV infection, sexually transmitted infections, and other health outcomes
*Formerly titled "Recommendations for Providers Counseling Male Patients and Parents Regarding Male Circumcision and the Prevention of HIV Infection, Sexually Transmitted Infections, and other Health Outcomes"
**Formerly titled "Background, Methods, and Synthesis of Scientific Information Used to Inform the 'Recommendations for Providers Counseling Male Patients and Parents Regarding Male Circumcision and the Prevention of HIV Infection, Sexually Transmitted Infections, and other Health Outcomes"
Program performance indicators
CDC has incorporated program performance indicators into its cooperative agreements with HIV prevention providers to improve program performance and accountability. All directly funded health departments and community-based organizations will report on measures of HIV prevention planning, service delivery, and evaluation activities. Performance indicators will be used to monitor progress in critical areas of HIV prevention.
Evaluation activities focus on results by:
- managing and measuring program performance
- improving the quality of HIV prevention programs
- promoting accountability
- decreasing HIV infections
- planning at the community level
- enhancing HIV prevention activities
- counseling, testing, and referral services
- partner counseling and referral services
- prevention for people with HIV
- health education and risk-reduction activities
- prevention of perinatal HIV transmission
- counseling, testing, and referral services
- evaluating reporting compliance
- capacity building activities
Resources
Program evaluation projects and resources
- Reduced sexual risk behaviors among people living with HIV: Results from the healthy relationships outcome monitoring project
- Evaluation of an HIV prevention intervention for African Americans and Hispanics: Findings from the VOICES/VOCES community-based organization behavioral outcomes
Other resources
- EvaluationWeb® is a data collection, analysis, and reporting tool for CDC users and DHP-funded HIV prevention program recipients. E-authentication is required for all EvaluationWeb® users.